Evaluation of dodecylmaltoside as a permeability enhancer for insulin using human carcinoma cells

Journal of Pharmaceutical Sciences

Volumn 94, Issue 2, 2005, Pages 246-255

  Tirumalasetty, Phani Prasanth ^a   Eley, John G ^b  

^a AUBURN UNIVERSITY   (United States)

^b PALM BEACH ATLANTIC UNIVERSITY   (United States)

Author keywords

Caco 2; Cell culture; Drug transport; Permeability; Tight junction

Indexed keywords

DODECYLMALTOSIDE; INSULIN; LUCIFER YELLOW; MALTOSE; MANNITOL; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PENETRATION; DRUG TRANSPORT; ELECTRIC RESISTANCE; EPITHELIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PERMEABILITY; SCINTILLATION; TIGHT JUNCTION;

EID: 14344266887     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20234     Document Type: Article

References (33)

1. Lee VHL, Yamamoto A. 1990. Penetration and enzymatic barrier to peptide and protein absorption. Adv Drug Delivery Rev 4:171-207.
2. Yamamoto A, Okagawa T, Kotani A, Uchiyama T, Shimura T, Tabata S, Konda S, Muranishi S. 1997. Effects of different absorption enhancers on the permeation of Ebiratide, an ACTH analogue, across intestinal membranes. J Pharm Pharmacol 49: 1057-1061.
3. Banga AK, Chein YW. 1988. Systemic delivery of therapeutic peptides and proteins. Int J Pharm 48:15-50.
4. Muranishi S. 1990. Absorption enhancers. Grit Rev Ther Drug Carrier Syst 7:1-33.
5. Saffran M, Bedra C, Kumar S, Nackers D. 1988. Vasopressin: A model for the study of effect of additives on the oral and rectal administration of peptide drugs. J Pharm Sci 77:33-38.
6. Tanaka K, Fujita T, Yamamoto Y, Murakami M, Yamamoto A, Muranishi S. 1996. Enhancement of intestinal transport of thyrotropin-releasing hormone via a carrier-mediated transport system by chemical modification with lauric acid. Biochem Biophys Acta 1283:119-126.
7. Yodoya E, Uemura K, Tenma T, Fujita T, Murakami M, Yamamoto A, Muranishi M. 1994. Enhanced permeability of tetragastrin across the rat membrane and its reduced degradation by acylation with fatty acids. J Pharmacol Exp Ther 271:1509-1513.
8. Asada H, Douen T, Murakami M, Yamamoto A, Muranishi M. 1995. Absorption characteristics of chemically modified insulin derivatives with various fatty acids. J Pharm Sci 84:682-687.
9. Anderson JM, Van Itallie CM. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:G467-G475.
10. Pillion DJ, Hosmer S, Meezan E. 1988. Dodecyl-maltoside mediated nasal and ocular absorption of lyspro-insulin: Independence of surfactant action from multimer dissociation. Pharm Res 15(10): 1637-1639.
11. Artursson P, Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M. 1990. Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier. J Control Release 11:25-40.
12. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749.
13. Hilgers AR, Conradi RA, Burton PS. 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910.
14. Eley J, Tirumalashetty P. 2001. In vitro assessment of alkylglycosides as permeability enhancers. AAPS PharmSciTech 2(3): 1-7 (article 12).
15. Tsukamoto T, Nigam SK. 1999. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol 276: F737-F750.
16. Furuse M, Sasaki H, Tsukita S. 1999. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147(4):891-903.
17. Morita K, Sasaki H, Furuse M, Tsukati S. 1999. Endothelial claudin: Claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147(1):185-194.
18. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukati S. 1999. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2 and ZO-3 with the COOH termini of claudins. J Cell Biol 147(6):1351-1363.
19. Daugherty AL, Mrsny RJ. 1999. Regulation of the intestinal epithelial paracellular barrier. Pharm Sci Technol Today 2(7):281-287.
20. Hochman J, Artursson P. 1994. Mechanism of absorption enhancement and tight junction regulation. J Control Release 29:253-267.
21. Murakami M, Kusanoi Y, Takada K, Muranishi S. 1992. Assessment of enhancing ability of medium-chain alkyl saccharides as new absorption enhancers in rat rectum. Int J Pharm 79:159-169.
22. Bolte G, Wolburg H, Beuermann K, Stocker S, Stern M. 1998. Specific interaction of food proteins with apical membrane of the human intestinal cell lines Caco-2 and T84. Clin Chim Acta 270:151-167.
23. Delie F, Rubas W. 1997. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14(3):221-286.
24. Sulzbacher A, Jarosch A, Schuler R, Acerbi D, Ventura P, Puccini P, Woodcock BG. 1998. Validation of a Caco-2 cell monolayer culture for drug transport studies. Int J Clin Pharmacol Ther 36(2): 86-89.
25. Liang E, Kelli C, Mehran Y. 2000. Evaluation of an accelerated Caco-2 cell permeability model. J Pharm Sci 89(3):336-345.
26. Artursson P, Karlson J. 1991. Correlation between oral drug absorption in humans and apparent permeability coefficient in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175(3):880-885.
27. Helenius A, Simons K. 1975. Solubilization of membranes by detergents. Biochim Biophys Res Commun 415:29-79.
28. Gullikson GW, Cline WS, Lorenzsonn V, Benz L, Olsen WA, Bass P. 1977. Effect of anionic surfactants on hamster small intestinal membrane structure and function: Relationship to surface activity. Gastroenterology 73:501-511.
29. Claude P, Goodenough D. 1973. Fracture faces of zonulae occludens from tight and leaky epithelia. J Cell Biol 58:390-400.
30. Schilling JR, Mitra AK. 1990. Intestinal mucosal transport of insulin. Int J Pharm 62:53-64.
31. Greenwood R, Al-Achi A. 1997. Human insulin diffusion profile through a layer of Caco-2 cells. Drug Dev Ind Pharm 23(2):221-224.
32. Madara JL, Barenberg D, Carlson S. 1986. Effect of cytochalasin D on occluding junctions of intestinal absorptive cells: Further evidence that the cytoskeleton may influence paracellular pathway and junction charge selectivity. J Cell Biol 102(6):2125-2136.
33. Lee VHL, Yamamoto A, Kompella UB. 1991. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Rev Ther Drug Carrier Syst 8(2):91-192.